Arcus and Summit team up to test kidney cancer drug combo

Go back to Arcus and Summit team up to test kidney cancer drug combo
(NYSE: RCUS) Delayed: 24.41 +0.58 (2.43%)
Previous Close $23.83    52 Week High $ 
Open $23.89    52 Week Low $ 
Day High $24.58    P/E N/A 
Day Low $23.75    EPS $ 
Volume 795,188       

Stratcomm Media, Ltd. (NASDAQ: SMMT) Delayed: 17.59 +0.42 (2.45%)
Previous Close $17.17    52 Week High $19.75 
Open $17.36    52 Week Low $4.26 
Day High $17.62    P/E N/A 
Day Low $16.82    EPS $0.00 
Volume 5,754,954